These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7762743)
41. Comments to "a rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M Gene; 2014 Jan; 534(2):451-2. PubMed ID: 24100083 [No Abstract] [Full Text] [Related]
42. Comments to “A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency”. Concolino P; Mello E; Rossodivita A; Giardina B; Capoluongo E Gene; 2014 Jan; 534(2):449-450. PubMed ID: 24501745 [No Abstract] [Full Text] [Related]
43. Salt wasting phenotype in a compound heterozygous girl with P482S mutation associated with anovel mutation of CYP21 gene (Q481P). Di Pasquale G; Wasniewska M; Caruso M; Salzano G; Coco M; Lombardo F; De Luca F J Endocrinol Invest; 2005 Dec; 28(11):1038-9. PubMed ID: 16483186 [No Abstract] [Full Text] [Related]
44. Non classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in families from a Greek island with a closed society. Trakakis E; Chryssikopoulos A; Basios G; Trompoukis P; Sarandakou A; Spyropoulou M; Salamalekis E; Karanikolopoulos P; Salamalekis G; Skarpas P; Kassanos D Clin Exp Obstet Gynecol; 2008; 35(4):267-71. PubMed ID: 19205441 [TBL] [Abstract][Full Text] [Related]
46. An improved method for the detection of heterozygosity of congenital virilizing adrenal hyperplasia. Lejeune-Lenain C; Cantraine F; Dufrasnes M; Prevot F; Wolter R; Franckson JR Clin Endocrinol (Oxf); 1980 Jun; 12(6):525-35. PubMed ID: 6249520 [TBL] [Abstract][Full Text] [Related]
47. Acne and non-classic congenital adrenal hyperplasia. Falhammar H N Z Med J; 2008 Jun; 121(1275):94-5. PubMed ID: 18551162 [No Abstract] [Full Text] [Related]
48. [Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency presenting with erythrocytosis]. Ramos I; Regadera A; Román P; Ezquieta B Med Clin (Barc); 2008 Nov; 131(16):638-9. PubMed ID: 19080859 [No Abstract] [Full Text] [Related]
49. [Congenital adrenal hyperplasia due to 21 hydroxylase deficiency--case report]. Vlaski J; Katanić D; Kavecan I; Dautović S; Vorgucin I Med Pregl; 2008; 61(3-4):183-6. PubMed ID: 18773697 [TBL] [Abstract][Full Text] [Related]
50. [Study of the transmission of the 21-hydroxylase deficiency through the hormonal screening and the HLA-typing (author's transl)]. Bartolotta E; Migliori C; Gabrielli A; Oggiano N; Catassi C; Leone L Pediatr Med Chir; 1981; 3(4):287-90. PubMed ID: 6283486 [No Abstract] [Full Text] [Related]
51. An unexpected finding in a 46,XX patient with congenital adrenal hyperplasia. Salle L; Lachâtre D; Galinat S J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):102113. PubMed ID: 33744520 [No Abstract] [Full Text] [Related]
52. Heterozygous POR gene mutations in a patient with congenital adrenal hyperplasia. Gusmano C; Calogero AE; Cannarella R Endocrine; 2022 Aug; 77(2):401-402. PubMed ID: 35635658 [No Abstract] [Full Text] [Related]
53. CYPs, SNPs, and molecular diagnosis in the postgenomic era. Vilain E Clin Chem; 1998 Dec; 44(12):2403-4. PubMed ID: 9836703 [No Abstract] [Full Text] [Related]
54. Genetic analysis does not confirm non-classical congenital adrenal hyperplasia in more than a third of the women followed with this diagnosis. Alcantara-Aragon V; Martinez-Couselo S; Tundidor-Rengel D; Webb SM; Carreras G; Espinos JM; Chico A; Blanco-Vaca F; Corcoy R Hormones (Athens); 2014; 13(4):585-7. PubMed ID: 25402394 [No Abstract] [Full Text] [Related]
55. Hyperandrogenism in a child with multiple endocrine neoplasia type 1. García García E; Mangas Cruz MÁ; Guerrero Vázquez R; Navarro González E Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):132-133. PubMed ID: 30591325 [No Abstract] [Full Text] [Related]